Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sustained-release dexamphetamine feasibility study in crack-cocaine dependent patients receiving heroin-assisted treatment
2013-004024-11Phase 2Completed
- Sponsor
- Academic Psychiatric Center
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cocaine use disorder (CUD) comparing Dexamphetamine SR add-on with Placebo add-on (2 arms). Primary endpoint: Total number of days of crack-cocaine use during the 12-week study period. Started Jan 2014; status: completed.
02
Drugs
dexamfetamine sulfate
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on 2013-004024-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004024-11.